Abstract
The effect of increased gastric pH (obtained by pre-treatment with omeprazole) on the bioavailability of doxycycline monohydrate and doxycycline carrageenate has been investigated in 24 healthy volunteers, using an open, randomised, four-treatment, four-period, crossover, 2×2 factorial design. Each subject received a single dose of 100 mg of each of the doxycycline formulations with and without pre-treatment with omeprazole (40 mg daily for 7 days).
The two formulations were bioequivalent (rate and extent) during fasting without omeprazole pre-treatment, whereas after omeprazole, the monohydrate showed a highly significant decrease in bioavailability (38% for AUC and 45% for Cmax) compared to the carrageenate formulation, which was not affected by prior administration of omeprazole. Many of the subjects did not reach a therapeutic plasma level of doxycycline during the combination of omeprazole and doxycycline monohydrate, and most adverse events (mainly gastrointestinal) were reported after this combination.
As large populations of patients have a high gastric pH due to frequent use of H2-blockers, proton pump inhibitors and antacids, as well as to physiological achlorhydria, the decreased absorption of doxycycline monohydrate may well have a clinical impact, for example when the patients are treated with tetracyclines for an infection.
Similar content being viewed by others
References
Barr WH, Adir J, Garnetson L (1971) Decrease of tetracycline absorption in man by sodium bicarbonate. Clin Pharmacol Ther 12: 779–784
Hermansson J (1982) Rapid determination of tetracycline and lumecycline in human plasma and urine using high-performance liquid chromatography. J Chrom 232: 385–393
Gomeni R (1984) Pharm — an interactive graphic program for individual and population pharmacokinetic parameter estimation. Comput Biol Med 14: 24–34
Schuirmann D (1987) A comparison of the two one-sided test procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm 15: 657–680
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grahnén, A., Olsson, B., Johansson, G. et al. Doxycycline carrageenate — an improved formulation providing more reliable absorption and plasma concentrations at high gastric pH than doxycycline monohydrate. Eur J Clin Pharmacol 46, 143–146 (1994). https://doi.org/10.1007/BF00199878
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00199878